LUX-Head & Neck-1 trial with Afatinib Results #hncs16
Ezra Cohen, MD of the University of California at San Diego discusses the results of the LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent...
Author: ASTROHN2016
Added: 02/23/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Methotrexate